Finance and Investment Committee

The Finance and Investment Committee’s primary function is to monitor the financial health of AMIA and ensure that its assets are protected, its resources are used properly, and that AMIA complies with all applicable laws and reporting requirements. The committee reports to the Board.

Steven E. Labkoff, Chair, AstraZeneca Pharmaceuticals LP
Salome Aringo, AMIA
Ted Berry, Morgan Stanley Smith Barney LLC
Paul R. DeMuro, Latham & Watkins LLP
Mark A. Dente, GE Healthcare
Douglas K. Dew, Flagler Hospital
R. Scott Evans, Intermountain Healthcare/University of Utah
Daniel F. Foltz, CSC Consulting, Inc.
Paul Fu, Jr., Harbor – UCLA Medical Center
Karen Greenwood, AMIA
Sarah Ingersoll, University of Southern California
Eric Z. Silfen, Philips Healthcare
Justin B. Starren, Northwestern University Biomedical Informatics Center
Mark G. Weiner, University of Pennsylvania, School of Medicine
Peter Winkelstein, Children’s Hospital of Buffalo